skip to content

Haematology

DHPC | LPI

Solutions

Local Prescribing Information
See all Local Prescribing Information

Disclaimer - Kindly note that it takes approximately up to 6 months to implement the revised PI in commercial stocks imported into India after submission to the health authorities. All PIs notified to or approved by the CDSCO are published on this website for all the HCPs prescribing Roche drugs within 10 calendar days.

Safety Update Information for Healthcare Professionals. I understand the following:
1. The information contained in this website page is for the sole purpose of use and knowledge of Healthcare Professionals (HCPs) only.
2. If any Individual other than HCPs access the information contained in this website page and act thereon, then Roche will not be liable for any consequences in relation thereto.
3. Patients and their relatives should not access the information contained in this website page. They are advised to consult their treating physicians.
By clicking Agree, I hereby confirm that I am a Healthcare Professional and agree to the terms and conditions mentioned above.

©  Roche Products (India) Pvt. Ltd.  

Disclaimer: The images on this website are for representation purpose only and do not indicate actual patient outcomes or the effects of any product.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding one of our products, visit us at https://www.rocheindia.com/contactOR please call the Roche India Safety Unit on +91-98201 63752or E-mail us at [email protected]

Directors' Information

  • Financial Year 2024-2025

    • Mr. Simpson Emmanuel Vinod Kumar resigned as Managing Director with effect from December 15, 2024.

    • Ms. Claudia Bockstiegel resigned as Director with effect from August 31, 2024.

  • Financial Year 2023-2024

    • Mr. Narendra Varde resigned as a Director with effect from May 06, 2023